Rhythm Biosciences Ltd. ( (AU:RHY) ) has issued an update.
Rhythm Biosciences Ltd. announced the cessation of 1,000,000 ordinary fully paid employee securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This announcement may impact the company’s capital structure and could have implications for employee incentives and stakeholder confidence.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd. operates in the biotechnology industry, focusing on the development and commercialization of medical diagnostics. The company is primarily involved in creating innovative diagnostic technologies aimed at improving early detection and treatment outcomes for various diseases.
YTD Price Performance: -3.45%
Average Trading Volume: 347,823
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$24.37M
For an in-depth examination of RHY stock, go to TipRanks’ Stock Analysis page.